Sep 2026 · Announcement under Regulation 30 (LODR)-Credit Rating 24 Sep - CARE reaffirmed Birlasoft bank facilities at CARE AA+/Stable and CARE A1+ on September 24, 2026.
Source: Bse
IT stocks · Large cap · NSE
Birlasoft is an IT services company focused on AI-led capabilities and enterprise software. It recently onboarded new leaders and is investing in its sales team to pivot to a growth-oriented "AI First" organization amidst a challenging demand environment, aiming to return to revenue growth.
SMA20 -1.6% / mo · MACD + · sector +19.1pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Today's candle is provisional from the latest intraday quote; completed-candle scans remain unchanged.
Adjusted completed-session prices, rebased to 100
Investable fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend supports entry, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +7.3% · PAT +51.9% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +7% YoY · PAT +52% YoY · margin expansion · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,379 Cr | +7.3% | +2.2% |
| EBITDA | ₹223 Cr | +40.3% | -10.4% |
| Operating margin | 16.0% | +400 bps | -200 bps |
| PAT | ₹161 Cr | +51.9% | -8.5% |
| PAT margin | 11.7% | +343 bps | -137 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 65. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 61 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Asset-light IT companies deserve valuation support only when growth, margins, and cash conversion hold up.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in IT — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4 FY26 revenue grew 0.1% QoQ (INR) but declined in USD. Full-year FY26 revenue declined 1.2% (INR) / 6% (USD). EBITDA margins expanded significantly to 18.5% in Q4 and 16.3% for FY26, driven by operational efficiencies and strategic exits. Deal signings exceeded $200M for two consecutive quarters.
Despite strong margin expansion and deal wins, Birlasoft's revenue has been flat or declining for six consecutive quarters, reflecting a challenging demand environment and client-specific issues. Management is undertaking a second restructuring with new leadership and substantial sales team expansion, betting on an "AI First" strategy to drive future growth. The success of these investments and the conversion of delayed deals are critical.
Deploying AI-powered solutions like Cogito platform to accelerate enterprise software development, automate processes, and enhance decision-making.
Expect to increase sales team strength by 30-40% YoY by mid-FY27 to enhance capacity and capability, with additions in US and Europe geos.
New leader from SAP with 25 years of experience hired to lead the ERP business, with hopes to get it back to growth.
Scaling Gen AI services across the North American P&C market; management expects BFSI to be a strong growth vertical going forward.
Sales team strength expected to go up by 30% to 40% on a year-on-year basis by the middle of FY '27.
Onboarded Vikram Puranik as COO, new leaders for Data & AI practice, ERP practice, Global Partnerships & Alliances, and Lifesciences vertical.
Benefited by incremental one-offs in Q4 versus Q3, including currency tailwinds contributing 170 basis points to margin.
Took the benefit of available tax concessions in some global operations in Q4, which acted as a tailwind.
Lower provisions for performance-based compensation and leave encashment in Q4 contributed 170 basis points to margin.
Sustained macroeconomic headwinds led to some client-specific issues and erosion of revenue.
An operational issue at one MedTech customer affected volume growth in Q4, reflected in the Life Sciences business.
Upfront productivity benefits had to be passed on because of AI deals won, denting revenue.
Bold decisions to walk away from several non-profitable revenue streams affected overall revenue but contributed to margin expansion.
The demand environment is challenging, marked by uncertainty, making future predictions difficult.
Success depends on new leaders and expanded sales team settling down, building pipeline, and converting orders.
Larger players are now competing for mid-sized deals due to AI creating a level playing field.
Outcome-based, fixed-price AI deals can lead to immediate revenue deflation, with revenue catching up in future quarters.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
QoQ is crucial to track sequential momentum, especially with new investments and deal conversions. YoY is important for full-year performance and margin expansion context, but the company's recent performance issues make QoQ more indicative of immediate trends.
INR 13,486 million (0.1% QoQ, 2.4% YoY); $145.3 million (-3.7% QoQ CC, USD)
INR 53,100 million (-1.2% YoY); $597.5 million (-6% YoY USD)
18.5% (+30 bps QoQ)
16.3% (+333 bps YoY from 13% in FY25)
Entire focus going forward will be centered around sales, pipeline generation, and order booking, especially for outcome-based and managed services engagements.
Intent to pivot to a growth-oriented "AI First" organization with significant changes in delivery mechanism, expecting benefits over the next couple of quarters.
Management strongly believes the ERP business will only continue to improve from here with the new leader.
Committed to staying focused on sustained cash flow generation and prudent capital allocation.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Revenue growth | 6 consecutive quarters of flat/declining QoQ revenue. | Resumption of quarter-on-quarter revenue growth, indicating effectiveness of new investments. |
| Order booking (TCV) | $208M in Q4, second consecutive quarter above $200M. | Sustained strong order booking performance, substantially better than FY26, to build future revenue pipeline. |
| Sales team ramp-up effectiveness | 30-40% increase in sellers expected by mid-FY27. | Tangible improvement in pipeline generation and TCV conversion from new sales hires. |
| EBITDA margin | 18.5% in Q4 FY26. | Maintenance of steady-state EBITDA margins upward of 15% despite growth investments and one-off reversals. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 83rd percentile of the scored universe and 77th percentile within IT. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · IT: 77th pctile, median 69 · Large: 65th pctile, median 73
91 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse